Home LiteratureArticle Details
PMID: 2670680 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The structural basis of the high in vivo strength of the rRNA P2 promoter of Escherichia coli.

Gene ·Vol. 78 ·No. 1 ·1989-05-15 ·Pages 189-94

Lukacsovich T, Gaal T, Venetianer P

Abstract

Ribosomal RNA promoters of Escherichia coli are probably the strongest promoters in vivo and they can be used on plasmid vectors to express protein-coding sequences at a high rate. In fact, the P2 promoter of the rrnB gene is stronger (in vivo) than the tac promoter, which has a perfect consensus sequence. Conversion of the rrnB P2 promoter sequence to consensus significantly increases in vivo promoter strength. The removal of four nucleotides downstream of the -10 region also increases the strength of this promoter. On the other hand, shifting of the A + T-rich region upstream of this promoter by an 11-bp insertion drastically decreases in vivo activity. It is concluded that the two functionally important hexanucleotide sequences, -35 and -10, are necessary but not sufficient factors for the optimalization of in vivo promoter strength.

MeSH Terms
Base Sequence Escherichia coli/genetics Lac Operon Molecular Sequence Data Nucleic Acid Hybridization Plasmids Promoter Regions, Genetic Protein Biosynthesis RNA, Ribosomal/genetics Restriction Mapping Transcription, Genetic
Chemicals
RNA, Ribosomal
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lukacsovich T
Institute of Biochemistry, Biological Research Center, Szeged, Hungary.
Gaal T
Venetianer P
Article Info
Journal
Gene
Abbr.
Gene
ISSN
0378-1119
Published
1989-05-15
Pages
189-94
Language
English
Region
Netherlands
NLM ID
7706761
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]